XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.2
DERIVATIVE FINANCIAL INSTRUMENTS
6 Months Ended
Jun. 30, 2025
DERIVATIVE FINANCIAL INSTRUMENTS  
DERIVATIVE FINANCIAL INSTRUMENTS

11.    DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, and foreign exchange risk primarily through the use of derivative financial instruments.

The Company enters into foreign currency contracts with 30-day maturities to hedge its short-term balance sheet exposure, primarily intercompany, that are denominated in currencies (Euro, Mexican Peso, New Zealand Dollar, Chinese Renminbi, Swedish Krona, Canadian Dollar) other than the subsidiary’s functional currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in other expense, net in the condensed consolidated statements of income and comprehensive income (loss). To minimize foreign currency exposure, the Company had foreign currency contracts with notional amounts of $35,579 and $30,945 at June 30, 2025 and December 31, 2024, respectively. The foreign currency contracts are recorded in the condensed consolidated balance sheets at fair value and resulting gains or losses are recorded in other expense (income), net in the condensed consolidated statements of income and comprehensive income (loss). During the three and six months ended June 30, 2025, the Company had gains of $1,193 and $1,070, respectively, and during the three and six months ended June 30, 2024, the Company had a gain of $31 and a loss of $81, respectively on foreign currency contracts which is included in other expense (income), net and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other expense (income), net.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements on its variable-rate debt. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. In March 2022 the Company entered into an interest rate swap with a notional amount of $40,000 that matures in December 2026. In March 2023, the Company executed amendments to the existing swaps to amend the index on the interest rate derivatives from LIBOR to SOFR. These amendments had no material financial impact to the Company’s operations or financial position. In September 2024, the Company entered into an additional interest rate swap with a notional amount of $50,000 that matures in September 2027.

The changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive loss and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. During 2025 and 2024, such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.

As of June 30, 2025, the Company estimates that $1,017 will be reclassified as a decrease to interest expense over the next twelve months related to its interest rate derivatives. The Company does not use derivatives for trading or speculative purposes.

The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the condensed consolidated balance sheets as of June 30, 2025 and December 31, 2024:

Asset Derivatives

Fair value as of:

Derivatives designated as

Balance Sheet

June 30, 

December 31, 

hedging instruments

    

Location

    

2025

    

2024

Foreign currency contracts

Prepaid expenses and other assets

$

105

$

Interest rate swaps

Other long-term assets

$

1,133

$

2,575

$

1,238

$

2,575

Liability Derivatives

Fair value as of:

Derivatives designated as

Balance Sheet

June 30, 

December 31, 

hedging instruments

    

Location

    

2025

    

2024

Foreign currency contracts

Accrued liabilities

$

$

137

The tables below present the effect of cash flow hedge accounting on other comprehensive income (loss) (“OCI”) for the three and six months ended June 30, 2025 and 2024:

Amount of pre-tax (loss) gain recognized

Amount of pre-tax (loss) gain recognized

in OCI on derivatives

in OCI on derivatives

Derivatives in cash flow hedging relationships

Three months ended June 30, 

Six months ended June 30, 

    

2025

    

2024

    

2025

    

2024

Interest rate swaps

$

(161)

$

360

$

(641)

$

1,295

Amount of pre-tax gain reclassified

Amount of pre-tax gain reclassified

from accumulated OCI into income

from accumulated OCI into income

Location of gain reclassified

Three months ended June 30, 

Six months ended June 30, 

from accumulated OCI into income

2025

2024

    

2025

    

2024

Interest expense

$

379

$

1,033

$

755

$

2,069

The table below presents the line items that reflect the effect of the Company’s derivative financial instruments on the condensed consolidated statements of income and comprehensive income (loss) for the three and six months ended June 30, 2025 and 2024:

Total amounts of income and expense

Total amounts of income and expense

line items presented that reflect the

line items presented that reflect the

effects of cash flow hedges recorded

effects of cash flow hedges recorded

Three months ended June 30, 

Six months ended June 30, 

Derivatives designated as hedging instruments

    

Income Statement Location

    

2025

    

2024

    

2025

    

2024

Interest rate swaps

 

Interest Expense

$

3,552

$

3,384

$

7,187

$

6,772

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives as of June 30, 2025 and December 31, 2024. The net amounts of derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented in the condensed consolidated balance sheets:

Derivative assets:

Net amounts

Gross amounts

of assets

Gross amounts not offset in the consolidated 

As of 

Gross amounts

offset in the

presented in the

balance sheets

June 30, 

of recognized

consolidated

consolidated

Financial

Cash collateral

2025

    

assets

    

balance sheets

    

balance sheets

    

instruments

    

received

    

Net amount

Derivatives

$

1,238

$

$

1,238

$

$

$

1,238

Net amounts

Gross amounts

of assets

Gross amounts not offset in the consolidated 

As of 

Gross amounts

offset in the

presented in the

balance sheets

December 31, 

of recognized

consolidated

consolidated

Financial

Cash collateral

2024

    

assets

    

balance sheets

    

balance sheets

    

instruments

    

received

    

Net amount

Derivatives

$

2,575

$

$

2,575

$

$

$

2,575

Derivative liabilities:

Net amounts

Gross amounts

of liabilities

Gross amounts not offset in the consolidated 

As of 

Gross amounts

offset in the

presented in the

balance sheets

December 31, 

of recognized

consolidated

consolidated

Financial

Cash collateral

2024

    

liabilities

    

balance sheets

    

balance sheets

    

instruments

    

received

    

Net amount

Derivatives

$

137

$

$

137

$

$

$

137

The Company has agreements with each of its derivative counterparties that contain a provision where if the Company either defaults or is capable of being declared in default on any of its indebtedness, then the Company could also be declared in default on its derivative obligations.